[Deregulated splicing machinery in myelodysplastic syndromes].
Seishi
S
Ogawa
D000818:Animals; D005091:Exons / Q000235:genetics; D006801:Humans; D051379:Mice; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000235:genetics* / Q000503:physiopathology; D009687:Nuclear Proteins / Q000235:genetics; D010750:Phosphoproteins / Q000235:genetics; D012326:RNA Splicing / Q000235:genetics*; D000072260:RNA Splicing Factors; D017413:Ribonucleoprotein, U2 Small Nuclear / Q000235:genetics; D012261:Ribonucleoproteins / Q000235:genetics; D000068103:Serine-Arginine Splicing Factors; D000072668:Splicing Factor U2AF
D009687:Nuclear Proteins; D010750:Phosphoproteins; D000072260:RNA Splicing Factors; D017413:Ribonucleoprotein, U2 Small Nuclear; D012261:Ribonucleoproteins; C112491:SF3B1 protein, human; D000072668:Splicing Factor U2AF; C076753:U2AF1 protein, human; C484334:ZRSR2 protein, human; C073288:SRSF2 protein, human; D000068103:Serine-Arginine Splicing Factors